Should chemotherapy in neoadjuvant setting in node positive breast cancers be guided by biology over magnitude of tumour burden?. (October 2020) - Provenzano, E.; Garreffa, E.; Wignarajah, P.; Borkar, N.; Psychogiou, V.; Newton, A.; Benson, J.; Forouhi, P.; Hughes-Davies, L.; Wilson, C.; McAdam, K.; Russell, S.; et al.